日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors

对20000例成人和儿童肿瘤的突变过程进行全面分析

Villa, Matteo; Malighetti, Federica; De Sano, Luca; Villa, Alberto Maria; Cordani, Nicoletta; Aroldi, Andrea; Antoniotti, Marco; Caravagna, Giulio; Graudenzi, Alex; Piazza, Rocco; Mologni, Luca; Ramazzotti, Daniele

Author Correction: Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer

作者更正:对超过3600个肿瘤中KEAP1/NFE2L2改变的整合分析揭示了NRF2表达特征可作为癌症预后生物标志物。

Crippa, Valentina; Cordani, Nicoletta; Villa, Alberto Maria; Malighetti, Federica; Villa, Matteo; Sala, Luca; Aroldi, Andrea; Piazza, Rocco; Cortinovis, Diego; Mologni, Luca; Ramazzotti, Daniele

Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer

对超过3600个肿瘤中KEAP1/NFE2L2改变的整合分析揭示了NRF2表达特征可作为癌症预后生物标志物。

Crippa, Valentina; Cordani, Nicoletta; Villa, Alberto Maria; Malighetti, Federica; Villa, Matteo; Sala, Luca; Aroldi, Andrea; Piazza, Rocco; Cortinovis, Diego; Mologni, Luca; Ramazzotti, Daniele

Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy

病例报告:成功使用emapalumab治疗CAR-T细胞疗法后出现严重神经毒性和噬血细胞性淋巴组织细胞增生症样症状的成人B细胞急性淋巴细胞白血病

Manghisi, Beatrice; Cotilli, Giulia; Fedele, Marilena; Perfetti, Paola; Terruzzi, Elisabetta; Verga, Luisa; Borin, Lorenza Maria; Carrer, Andrea; Fumagalli, Monica; Ferrari, Maria Beatrice; Moretti, Alex; Rona, Roberto; Benini, Annalisa; Vergnano, Beatrice; Palumbo, Giovanni; Zincone, Alessandra; Maglia, Oscar; Scollo, Chiara; Steidl, Carolina; Iovino, Lorenzo; Balduzzi, Adriana; Piazza, Rocco; Gambacorti-Passerini, Carlo; Parma, Matteo; Aroldi, Andrea

Real-world collection of secondary myeloid neoplasms after CD19 CAR-T cell therapy: first report of the ClonHema study

CD19 CAR-T细胞治疗后继发性髓系肿瘤的真实世界病例收集:ClonHema研究的首份报告

Farina, Mirko; Bernardi, Simona; Malagola, Michele; Re, Alessandro; Galli, Eugenio; Riva, Marcello; Cutini, Ilaria; Leoni, Alessandro; Martino, Massimo; Ferrari, Silvia; Battipaglia, Giorgia; Novo, Mattia; Musso, Maurizio; Grillo, Giovanni; Santarone, Stella; Krampera, Mauro; Aroldi, Andrea; Polverelli, Nicola; Arcaini, Luca; Xhahysa, Besjana; Avenoso, Daniele; Tisi, Maria Chiara; Chiusolo, Patrizia; Russo, Domenico

Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis

基于多组学聚类分析的乳腺癌预后生物标志物

Malighetti, Federica; Villa, Matteo; Villa, Alberto Maria; Pelucchi, Sara; Aroldi, Andrea; Cortinovis, Diego Luigi; Canova, Stefania; Capici, Serena; Cazzaniga, Marina Elena; Mologni, Luca; Ramazzotti, Daniele; Cordani, Nicoletta

A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)

MEK1/2 抑制剂比美替尼联合 MET 抑制剂克唑替尼治疗 RAS 突变型晚期结直肠癌患者的 Ia/b 期研究 (MErCuRIC)

Aroldi, Francesca; Elez, Elena; André, Thierry; Perkins, Geraldine; Prenen, Hans; Popovici, Vlad; Gallagher, Peter; Houlden, Jennifer; Collins, Linda; Roberts, Corran; Rolfo, Christian; Di Nicolantonio, Federica; Grayson, Margaret; Boyd, Ruth; Bettens, Karolien; Delfavero, Jurgen; Coyle, Victoria; Lawler, Mark; Khawaja, Hajrah; Laurent-Puig, Pierre; Salto-Tellez, Manuel; Maughan, Tim S; Tabernero, Josep; Adams, Richard; Jones, Robert; Hennessy, Bryan T; Bardelli, Alberto; Peeters, Marc; Middleton, Mark R; Wilson, Richard H; Van Schaeybroeck, Sandra

A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301)

一项针对晚期癌症患者的 NUC-3373(一种靶向胸苷酸合成酶抑制剂)的 I 期开放标签剂量递增研究 (NuTide:301)

Spiliopoulou, Pavlina; Kazmi, Farasat; Aroldi, Francesca; Holmes, Thomas; Thompson, David; Griffiths, Lucinda; Qi, Cathy; Parkes, Matthew; Lord, Simon; Veal, Gareth J; Harrison, David J; Coyle, Vicky M; Graham, Jill; Jeffry Evans, Thomas R; Blagden, Sarah P

Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies

间变性淋巴瘤激酶 (ALK) 抑制剂可增强 CD47 阻断诱导的对 ALK 敏感和耐药的恶性肿瘤的吞噬作用

Malighetti, Federica; Villa, Matteo; Mauri, Mario; Piane, Simone; Crippa, Valentina; Crespiatico, Ilaria; Cocito, Federica; Bossi, Elisa; Steidl, Carolina; Civettini, Ivan; Scollo, Chiara; Ramazzotti, Daniele; Gambacorti-Passerini, Carlo; Piazza, Rocco; Mologni, Luca; Aroldi, Andrea

Idiopathic erythrocytosis: a germline disease?

特发性红细胞增多症:一种生殖细胞疾病?

Elli, E M; Mauri, M; D'Aliberti, D; Crespiatico, I; Fontana, D; Redaelli, S; Pelucchi, S; Spinelli, S; Manghisi, B; Cavalca, F; Aroldi, A; Ripamonti, A; Ferrari, S; Palamini, S; Mottadelli, F; Massimino, L; Ramazzotti, D; Cazzaniga, G; Piperno, A; Gambacorti-Passerini, C; Piazza, R